University of Michigan Medical Center Archives

Sarcopenia in the Prostate Cancer Patient

Posted by Mark A. Moyad, MD, MPH | Apr 2020

Mark A. Moyad, MD, MPH, the Jenkins/Pokempner Director of Complementary/Alternative Medicine at the University of Michigan Medical Center in the Department of Urology, discusses the consequences of androgen-deprivation therapy-related skeletal muscle loss. He goes on to discuss the prevalence of sarcopenia in prostate cancer patients, the clinical studies demonstrating the efficacy of incorporating exercise for the prevention or mitigation of sarcopenia, as well as the benefits and limitations of diet and over the counter supplements for the prevention of sarcopenia.

Urinary Health Issues Following Treatment for Prostate Cancer

Posted by Ryan P. Terlecki, MD, FACS | Mar 2020

Ryan P. Terlecki, MD, Vice Chair and Associate Professor of Urology, as well as Director of the Men’s Health Clinic at Wake Forest University Baptist Medical Center, discusses the relative incidence of urinary issues following primary and salvage prostate cancer therapies including radical prostatectomy, radiation therapy, and salvage cryotherapy. He goes on to describe challenges to urinary health for patients undergoing treatment, proposes language for counseling patients pre and post-operatively, as well as highlighting effective treatment options for various types of urinary issues.

State of the Art: Nutrition and Prostate Cancer

Posted by Mark A. Moyad, MD, MPH | Mar 2020

Mark A. Moyad MD, MPH, the Jenkins/Pokempner Director of Preventive/Complementary and Alternative Medicine (CAM) at the University of Michigan Medical Center in the Department of Urology, discusses how reducing caloric intake and improving heart health can help patients fight prostate cancer and reduce the odds of recurrent cancer. He also argues that experimenting with supplements along with cancer treatment can be disadvantageous and that over the counter drugs should only be taken with a certificate of analysis. Dr. Moyad further discusses how dietary changes for cancer patients will also improve their heart health, mental health, and quality of life.

Hormone Therapy in High Risk Prostate Cancer

Posted by Patrick W. McLaughlin, MD | Aug 2019

Patrick W. McLaughlin, MD, discusses balancing the therapeutic effects of androgen deprivation therapy (ADT) with the impact of quality of life (QOL). He examines the best timing and radiotherapy regimen combination to pair with ADT, as well as properly assessing individual patients’ risk factors and disease severity when choosing treatment options.

The Modern Definition of Successful Cancer Treatment – Cure with Quality of Life

Posted by Patrick W. McLaughlin, MD | Aug 2019

Patrick W. McLaughlin, MD, discusses the balance of cure versus quality-of-life when treating prostate cancer patients. He details his approach to ensuring optimal patient-preferred outcomes using physician-as-advocate decision-making, as well as individual anatomical and tumor characteristics in guiding treatment planning.